|
GW Pharmaceuticals Ltd is a United Kingdom-based company that operates as a biopharmaceutical company. The Company manufactures pharmaceutical products. The Company specializes in developing, processing, and manufacturing drugs in pharmaceutical preparations for human and veterinary uses. The Company serves customers worldwide.
|
|
Name |
Title |
Age |
Since |
Iain Ward |
Secretary & Director |
- |
2021 |
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
Stock A |
1 |
378,505,496 |
370,720,441 |
97.9% |
0 |
0.0% |
97.9% |
|
Company contact information |
|
GW Pharmaceuticals Ltd. Sovereign House Vision Park, Chivers Way Histon Cambridge, Cambridgeshire CB24 9BZ Phone : +44.1223.266800 Fax : +44.1223.235667 Web : http://www.gwpharm.com
|
|
|
Sector Bio Therapeutic Drugs
| | 1st jan. | Capi. (M$) |
 | GW PHARMACEUTICALS PLC | | 6 907 |
| | | |
 | GILEAD SCIENCES, INC. | -12.08% | 80 075 |
 | REGENERON PHARMACEUTICALS, INC. | 4.69% | 71 235 |
 | VERTEX PHARMACEUTICALS | 17.76% | 66 136 |
 | WUXI APPTEC CO., LTD. | -16.92% | 42 735 |
 | BIONTECH SE | -36.77% | 39 612 |
 | GENMAB A/S | -17.26% | 20 205 |
 | ARGENX SE | -3.17% | 17 597 |
 | BEIGENE, LTD. | -49.32% | 14 168 |
 | NEUROCRINE BIOSCIENCES, INC. | 1.19% | 8 237 |
 | LEGEND BIOTECH CORPORATION | -8.58% | 6 572 |
 | SAREPTA THERAPEUTICS, INC. | -21.01% | 6 224 |
 | HALOZYME THERAPEUTICS, INC. | 9.03% | 6 106 |
 | EXELIXIS, INC. | -2.84% | 5 696 |
 | INTRA-CELLULAR THERAPIES, INC. | 10.58% | 5 459 |
 | ASCENDIS PHARMA A/S | -29.09% | 5 324 |
 | BIOCON LIMITED | -6.76% | 5 197 |
 | MARAVAI LIFESCIENCES HOLDINGS, INC. | -19.86% | 4 417 |
 | ARROWHEAD PHARMACEUTICALS, INC. | -45.38% | 3 829 |
 | CEREVEL THERAPEUTICS HOLDINGS, INC. | -23.07% | 3 698 |
 | MIRATI THERAPEUTICS, INC. | -56.81% | 3 518 |
Connections : GW Pharmaceuticals plc
|